$1.89 - CLYM | Climb Bio, Inc. Common Stock

Climb Bio, Inc. Common Stock (CLYM)

Climb Bio, Inc. Common Stock

XNAS:CLYM

1.89

2.72%

Ask

$2.22 - 144.00

Bid

$1.84 - 11,990.00

Low

$1.85

High

$1.92

Open

$1.9

Prev Close

$1.84

52W High

3.3

52W Low

1.05

Volume

175550

Avg Vol (3m)

340505.3

Float

62390839.72

Chart

TendieTensor AI Analysis

Company

Asset Type: Common Stock

SIC Code: 2834

Sector: Health Technology

Industry: Biotechnology

Date Listed: 08/10/2021

Primary Exchange: XNAS

Climb Bio Inc is a clinical-stage biotechnology company developing therapeutics for patients with immune-mediated diseases. its product candidate, budoprutug, is an anti-CD19 monoclonal antibody that has demonstrated B-cell depletion and has the potential to treat a broad range of B-cell-mediated diseases.

Phone: 1-866-857-2596

Address: 20 William Street

Address 2: Suite 145

City: Wellesley Hills

State: MA

Postal Code: 02481

Website

TendieTensor AI Analyst Recommendation: —

Fundamentals

Total Employees:

P/E (TTM)

-2.520000

P/B (TTM)

0.728060

EPS

-0.19

Round Lot

100

Composit FIGI

BBG00ZNKL0K6

Share Class FIGI

BBG00ZNKL0L5

Share Class Shares Outstanding

67.76M

Weighted Shares Outstanding

67.76M

Technicals

RSI (14)

MACD Line

MACD Signal

SMA 20

SMA 50

EMA 50

Trend

Short Interest

—

Days to Cover

— —

Higher = harder to cover

Short Interest Δ

—

Prev: —

Short Volume Ratio (Today)

— —

5D avg: —

Squeeze Score (0–100)

—

Discussion